Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/NEUROGENE-INC-65218886/actualite/Neoleukin-Therapeutics-Inc-annonce-ses-resultats-pour-le-premier-trimestre-clos-le-31-mars-2023-43786261/?utm_source=whatsapp&utm_medium=social&utm_campaign=share